Managers / Q2 2025 · view latest →
Vestcor Inc
CIK 0001536925 · 140 CARLETON STREET, SUITE 400, FREDERICTON, A3, E3B 3T4 · 506-444-5800
Summary
Vestcor Inc reported $3.3B in U.S.-listed holdings across 1,154 positions for Q2 2025.
Its largest position, MSFT, represents 3.5% of the portfolio.
Compared with Q1 2025, the fund opened 99 new positions and exited 104.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 89.6% · $3.0B
- REIT · 6.9% · $227M
- ETP · 2.5% · $84M
- Other · 0.5% · $16M
- ADR · 0.3% · $11M
- Other · 0.2% · $6M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SKAASKECHERS U S A INC | NEW | +165.0K | 165.0K | +$10M | $10M |
| PBUSINVESCO EXCH TRADED FD TR II | NEW | +140.6K | 140.6K | +$9M | $9M |
| WOOFOOT LOCKER INC | NEW | +350.0K | 350.0K | +$9M | $9M |
| INFORMATICA INC | NEW | +250.0K | 250.0K | +$6M | $6M |
| EATBRINKER INTL INC | NEW | +29.3K | 29.3K | +$5M | $5M |
| BLUEPRINT MEDICINES CORP | NEW | +31.6K | 31.6K | +$4M | $4M |
| JBS N.V. | NEW | +265.8K | 265.8K | +$4M | $4M |
| TIGOMILLICOM INTL CELLULAR S A | NEW | +102.3K | 102.3K | +$4M | $4M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $3.6B | 1,192 | May 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $3.5B | 1,157 | Feb 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $3.3B | 1,176 | Nov 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $3.3B | 1,154 | Aug 8, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $3.0B | 1,159 | May 8, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $3.0B | 1,205 | Feb 10, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $3.2B | 1,171 | Nov 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $3.0B | 1,178 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $2.9B | 1,261 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $3.0B | 1,248 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $2.7B | 1,305 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $2.7B | 1,083 | Aug 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $2.7B | 1,209 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 1,296 | Feb 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $2.6B | 1,391 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $2.7B | 1,375 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $2.9B | 1,439 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $2.8B | 1,434 | Feb 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $2.8B | 1,313 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $3.0B | 1,313 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $2.7B | 1,156 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $2.4B | 976 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $2.2B | 920 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.9B | 860 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $1.8B | 817 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $2.1B | 810 | Feb 12, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.